biomedicina slovenica


pr=Brauch : 14

  1. Rokavec Matjaž; Schroth Werner; Amaral Sandra M; Fritz Peter; Antoniadou Lydia; Glavač Damjan; Simon Wolfang; Schwab Matthias; Eichelbaum Michel; Brauch Hiltrud
    A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer
    2008
  2. Rokavec Matjaž; Justenhoven Christina; Schroth Werner; Istrate Monica Adina; Haas Susanne; Fischer Hans-Peter; Vollmert Caren; Illig Thomas; Hamann Ute; Ko Yon-Dschun; Glavač Damjan; Brauch Hiltrud
    A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    2007
  3. Stražišar M; Smerkolj S; Brauch H; Evfremov G; Maček M; Medica I; Terzić R; Glavač D
    Screening for genetic alterations in PRNP gene of six different populations with determination of codon 129 genotype - a multicentre study
    2005
  4. Brauch H; Weirich G; Brieger J; Glavač D; Rodl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Mašera A
    VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation
    2000
  5. Glavač Damjan; Brauch Hiltrud
    Molecular genetics of the von Hippel-Lindau syndrome
    1996
  6. Brauch H; Filipowicz M; Feurer M; Roedl H; Hoefler H; Stoerkel St; Glavač D
    Genetic origin of renal cell carcinoma
    1995
  7. Brauch H; Neumann HPH; Wittke C; Jaenig H; Hoefler H; Glavač D
    Germline mutations in the von Hippel-Lindau (VHL) Tumor suppressor gene in VHL families from central Europe: correlation with phenoype and presymptomatic diagnosis
    1996
  8. Streicher T; Glavač D; Brauch H
    Ophthalmologische und genetische Aspekte der von Hippel-Lindau Angiomatosis
    1996
  9. Neuman HPH; Berger DP; Zaeuner I; Kishida T; Zbar B; Pausch F; Glavač D; Brauch H
    The pheochromocytoma type of von Hippel-Lindau disease (VHL) in the Freiburg VHL study is associated with a point mutation
    1994
  10. Brauch H; Glavač D; Pausch F; Masek O; Chen E; Kishida T; Latif F; Lerman MI; Zbar B; Hoefler H; Neuman HPH
    Germline mutation screening and predictive testing in families with von Hippel-Lindau disease
    1994
  11. Glavač Damjan; Neumann Hartmut PH; Wittke Claudia; Jaenig Hendrik; Mašek Otakar; Streicher Teodor; Pausch Friederike; Engelhardt Dieter; Plate Karl H; Hoefler Heinz; Chen Fan; Zbar Berton; Brauch Hiltrud
    Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe
    1996
  12. Brauch Hiltrud; Glavač Damjan; Neumann Hartmut PH
    Germline mutations in the VHL tumor suppressor gene in patients with von Hippel-Lindau disease: correlation with phenotypes and presymptomatic diagnosis
    1996
  13. Neumann Hartmut PH; Eng Charis; Mulligan Lois M; Glavač Damjan; Zaeuner Ingeborg; Ponder Bruce A J; Crossey Paul A; Maher Eamonn R; Brauch Hiltrud
    Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II
    1995
  14. Brauch Hiltrud; Kishida Takeshi; Glavač Damjan; Chen Fan; Pausch Friederike; Hoefler Heinz; Latif Farida; Lerman Michael I; Zbar Berton; Neumann Hartmut PH
    Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black forest region of Germany: evidence for a founder effect
    1995


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics